Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Bingwen, Zhu"'
Autor:
Qiongdan Hu, Bingwen Zhu, Guoqiang Yang, Jian Jia, Honglian Wang, Ruizhi Tan, Qiong Zhang, Li Wang, Fahsai Kantawong
Publikováno v:
Journal of Pharmacological Sciences, Vol 151, Iss 2, Pp 72-83 (2023)
Bone marrow-derived mesenchymal stem cells (MSCs) show antifibrotic activity in various chronic kidney diseases. Here, we aimed to investigate whether Calycosin (CA), a phytoestrogen, could enhance the antifibrotic activity of MSCs in primary tubular
Externí odkaz:
https://doaj.org/article/d8f5a5cab01e46e0b4cef2fadfff29b5
Publikováno v:
Journal of Natural Medicines. 77:464-475
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed32112c4bb99ef3c12f8f71d23fe098
https://doi.org/10.1007/s11418-023-01685-y
https://doi.org/10.1007/s11418-023-01685-y
Autor:
Jieke Yang, Bingwen Zhu, Yufang Ni, Xiaoshuang Kang, Peng Liu, Qiongdan Hu, Qiong Zhang, Jianchun Li, Li Wang
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56281d1f77008791d05088cd181549a5
https://doi.org/10.2139/ssrn.4122164
https://doi.org/10.2139/ssrn.4122164
Autor:
Bingwen, Zhu, Yufang, Ni, Yi, Gong, Xiaoshuang, Kang, Huaiying, Guo, Xiaoheng, Liu, Jianchun, Li, Li, Wang
Publikováno v:
Life Sciences. 315:121331
Chronic kidney disease (CKD) is characterized by interstitial fibrosis, while limited treatment drugs are available. Ferroptosis is a newly identified process that can trigger tubular atrophy and fibrosis. The aim of this study is to investigate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2424fc411602b0e793e3cde851819ab6
https://doi.org/10.1016/j.lfs.2022.121331
https://doi.org/10.1016/j.lfs.2022.121331
Publikováno v:
Phytotherapy research : PTRREFERENCES. 36(1)
Renal tubular epithelial cell (TEC) injury and fibrosis are the key factors of the pathogenesis of chronic kidney disease. Here, we reported that tectorigenin is effectively protected against obstructive nephropathy established by unilateral ureteral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::493df096d0923ddb395d0aaabb31857c
https://pubmed.ncbi.nlm.nih.gov/34964161
https://pubmed.ncbi.nlm.nih.gov/34964161
Autor:
Xiaojia W; Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China., Jianchun L; Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China., Bingwen Z; Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China., Xingcan H; Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China., Yanmei D; Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China., Li W; Research Center of Integrated Traditional Chinese and Western Medicine, Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou 646000, Sichuan, China.
Publikováno v:
Evidence-based complementary and alternative medicine : eCAM [Evid Based Complement Alternat Med] 2022 Feb 27; Vol. 2022, pp. 2646022. Date of Electronic Publication: 2022 Feb 27 (Print Publication: 2022).